Home » Authors » Jim Stommen

Articles by Jim Stommen

Still optimistic: In a tough economy, VCs remain positive in their views on the med-tech sector

July 1, 2008

'Devastating' wounds: Common practice for war-zone surgeons

July 1, 2008

Physician/company ties draw close look by audience, media

June 1, 2008

Science, innovation abound; raising funds is the challenge

May 22, 2008

A look to 2020 offers both problems and opportunities

May 21, 2008

In difficult times, having 'calm urgency' is important

May 20, 2008

FDA official shares views on agency — but learns, too

May 19, 2008

Science, innovation abound; raising funds is the challenge

May 16, 2008

In tough economy, VCs still are optimistic about sector

May 15, 2008

Optimism, pessimism share podium in sector assessment

May 14, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...